Please login to the form below

Not currently logged in

Pharmalink appoints new chairman Anders Wiklund

The Swedish specialty pharma company has also appointed Elisabeth Lindner to its board of directors

Anders Wiklund has joined Swedish specialty pharma company Pharmalink AB as chairman of the board.

He previously spent 29 years with the Kabi and Pharmacia group of companies, holding roles such as UK managing director of KabiVitrum, president of KabiVitrum International in Sweden, president and CEO of KabiVitrum and KabiPharmacia in the US.

In his new role Wiklund, who currently serves on the boards of QuatRX, EffRx, Clavis Pharma and Life Medical, will take over from Pharmalink's outgoing chairman Bengt Julander.

Julander, who founded the company in 1991, will remain on Pharmalink's board as a non-executive director, as will Lennart Hansson.

In Hansson's place on the board of directors Pharmalink has appointed Elisabeth Lindner, who joins from fellow Swedish pharmaceutical company Diamyd Medical AB.

"With Anders taking on the Chairman's role and Elisabeth joining the Board, Pharmalink is positioned for the next stage of development," said Johan Haggblad, managing director of Pharmalink.

"Anders' and Elisabeth's exceptional industry experience will be invaluable in ensuring we realise value for Pharmalink and for patients with significant unmet medical need."

15th November 2011


Featured jobs

Subscribe to our email news alerts


Add my company

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...